Saving changes...

Done

Error

COR-12 A Comprehensive Opioid Response - Health System Ingegration

COR-12 A Comprehensive Opioid Response - Health System Ingegration

COR-12 A Comprehensive Opioid Response - Health System Ingegration

Andrew B. Mendenhall, M.D.
Andrew B. Mendenhall, M.D.
on behalf of Washington State Pharmacy Association

$ 49.00 $ 49.00 $ 49.00

$ 49.00 $ 49.00 $ 49.00

$ 49.00 $ 49.00 $ 49.00
$ 49.00 $ 49.00 $ 49.00
Normal Price: $ 49.00 $ 49.00

Review:

Launch date: 28 Oct 2015

Expiry Date: 11 Nov 2018

Last updated: 13 Mar 2017

Reference: 161504

$ 49.00 $ 49.00 $ 49.00
$ 49.00 $ 49.00 $ 49.00
COR-12 A Comprehensive Opioid Response - Health System Ingegration
Exam is embedded in the course
No Exam Available

Latest User Comments

I would like to...

Course Availability

This course is only available to trainees days after purchase. It would need to be repurchased by the trainee if not completed in the allotted time period. This course is no longer available. You will need to repurchase if you wish to take the course again.

Description

ACPE UAN 0130-0000-15-123-H05-P | CPE Credits 1.0 hr | Activity Type: Knowledge |
Disclosure: None | Initial Release date: 11/11/2015 | Expiration date: 11/11/2018

This CE is designed for pharmacist to develop a greater understanding of the disease of addiction and be able to integrate this information into clinical practice.

You will be required to view the video, and take an exam at the end of the video. Continuing education credits will be uploaded to the CPE Monitor if you pass the exam with a 70% score or better.

To ensure you receive credit for your CE, please verify that your NABP e-Profile ID and Date of Birth have been entered correctly on your Education Portal profile.

Click “My Profile” on the left of the homepage. Scroll down and click “CPE Monitor Integration Details.”Be sure to click “Save Changes” when complete.

If you need to verify your number or have not yet registered for one, please visit www.MyCPEMonitor.net. You will only have 60 days to upload your CE credits from the activity date.


Objectives

Objective
Develop a greater understanding of the disease of addiction and be able to integrate this information into clinical practice.
Define clinical treatment options to support patients in their journey of recovery.
Develop a working knowledge of the following:
-The concept of salience and how this applies in the context of DSM-V and the symptom of craving.
-The use of agonist, partial agonist and antagonist therapies in the treatment of opioid use disorders.
Recall the latest infor
Andrew B. Mendenhall, M.D.

Author Information Play Video Bio

Andrew B. Mendenhall, M.D.
on behalf of Washington State Pharmacy Association

Andrew B. Mendenhall, M.D. is Medical Director of Hazelden in Beaverton, Ore. Dr. Mendenhall was co-founder of HealthWorksNW, a multidisciplinary addiction medicine and pain management clinic acquired by Hazelden, Center City, Minn., in the fall of 2012.
Dr. Mendenhall is board certified by the American Board of Addiction Medicine and the American Board of Family Medicine. He is also a diplomate of the American Academy of Pain Management.

He is a graduate of Oregon Health and Sciences University and completed family medicine residency at OHSU in 2003. He served OHSU as a clinical leadership fellow in 2004 prior to moving to Newberg, Ore., to enter practice in family medicine.

While working in family medicine, Dr. Mendenhall identified unmet care needs for patients with persistent pain diagnoses, drug and alcohol issues, and saw the confluence of these issues within patients who suffer from both pain management and chemical dependency diagnoses, simultaneously. Furthermore, Dr. Mendenhall became aware of the vast disparity in addiction medicine and pain management care that exists within the U.S. health delivery system.
Dr. Mendenhall concurrently became a consultant physician for Hazelden in Springbrook in 2005 and he pursued private fellowship training in pain management and spinal diagnostics.
In 2010, Dr. Mendenhall co-founded HealthWorksNW in response to the need for a subspecialty clinic that addresses the complex care needs of patients with co-occurring mental health, pain management, and addiction medicine issues.

Dr. Mendenhall's subspecialty is caring for the persistent pain patient with addiction and chemical dependency issues. He supervises complex medical detoxification, and provides multidisciplinary, integrative pain management consultation.

Dr. Mendenhall's primary clinical interest is helping patients remain clean and sober through the provision of relapse prevention pharmacotherapies. These therapies are combined with different forms of abstinence-based, outpatient and residential treatment, and coordination of a full-spectrum of integrative pain management modalities.

Current Accreditations

This course has been certified by or provided by the following Certified Organization/s:

  • Accreditation Council for Pharmacy Education (ACPE)
  • 1.00 Hours

Faculty and Disclosures

Additional Contributors

Conflicts Declared

Conflicts of Interest declaration by Author:

null

User Reviews (0)

Go Back

Loading...


Saving changes...

Done

Error